Literature DB >> 22187460

Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt.

Ty Dale Troutman1, Wei Hu, Stephanie Fulenchek, Tetsuo Yamazaki, Tomohiro Kurosaki, J Fernando Bazan, Chandrashekhar Pasare.   

Abstract

Toll like receptors (TLRs) use Toll-IL-1 receptor (TIR) domain-containing adapters, such as myeloid differentiation primary response gene 88 (MyD88) and TIR domain-containing adapter inducing IFN-β (TRIF), to induce activation of transcription factors, including NF-κB, MAP kinases, and IFN regulatory factors. TLR signaling also leads to activation of PI3K, but the molecular mechanism is not understood. Here we have discovered a unique role for B-cell adapter for PI3K (BCAP) in the TLR-signaling pathway. We find that BCAP has a functional N-terminal TIR homology domain and links TLR signaling to activation of PI3K. In addition, BCAP negatively regulates proinflammatory cytokine secretion upon TLR stimulation. In vivo, the absence of BCAP leads to exaggerated recruitment of inflammatory myeloid cells following infections and enhanced susceptibility to dextran sulfate sodium-induced colitis. Our results demonstrate that BCAP is a unique TIR domain-containing TLR signaling adapter crucial for linking TLRs to PI3K activation and regulating the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187460      PMCID: PMC3252926          DOI: 10.1073/pnas.1118579109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia.

Authors:  Gernot Schabbauer; Ulrich Matt; Philipp Günzl; Joanna Warszawska; Tanja Furtner; Eva Hainzl; Immanuel Elbau; Ildiko Mesteri; Bianca Doninger; Bernd R Binder; Sylvia Knapp
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

4.  Structural ties between cholesterol transport and morphogen signaling.

Authors:  J Fernando Bazan; Frederic J de Sauvage
Journal:  Cell       Date:  2009-09-18       Impact factor: 41.582

5.  The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs.

Authors:  Ariadne Androulidaki; Dimitrios Iliopoulos; Alicia Arranz; Christina Doxaki; Steffen Schworer; Vassiliki Zacharioudaki; Andrew N Margioris; Philip N Tsichlis; Christos Tsatsanis
Journal:  Immunity       Date:  2009-08-21       Impact factor: 31.745

6.  Mal connects TLR2 to PI3Kinase activation and phagocyte polarization.

Authors:  Sandra Santos-Sierra; Sachin D Deshmukh; Julia Kalnitski; Peter Küenzi; Matthias P Wymann; Douglas T Golenbock; Philipp Henneke
Journal:  EMBO J       Date:  2009-07-02       Impact factor: 11.598

7.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Authors:  Sunhwa Kim; Hiroyuki Takahashi; Wan-Wan Lin; Pascal Descargues; Sergei Grivennikov; Youngjun Kim; Jun-Li Luo; Michael Karin
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

8.  TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis.

Authors:  Tatsukata Kawagoe; Osamu Takeuchi; Yoshitsugu Takabatake; Hiroki Kato; Yoshitaka Isaka; Tohru Tsujimura; Shizuo Akira
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

9.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.

Authors:  Cameron R Stewart; Lynda M Stuart; Kim Wilkinson; Janine M van Gils; Jiusheng Deng; Annett Halle; Katey J Rayner; Laurent Boyer; Ruiqin Zhong; William A Frazier; Adam Lacy-Hulbert; Joseph El Khoury; Douglas T Golenbock; Kathryn J Moore
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

10.  Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.

Authors:  Maciej Lech; Onkar P Kulkarni; Stephanie Pfeiffer; Emina Savarese; Anne Krug; Cecilia Garlanda; Alberto Mantovani; Hans-Joachim Anders
Journal:  J Exp Med       Date:  2008-07-21       Impact factor: 14.307

View more
  73 in total

1.  CD19 controls Toll-like receptor 9 responses in human B cells.

Authors:  Henner Morbach; Jean-Nicolas Schickel; Charlotte Cunningham-Rundles; Mary Ellen Conley; Ismail Reisli; Jose Luis Franco; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

2.  Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo.

Authors:  Rajakumar Mandraju; Sean Murray; James Forman; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

3.  A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway.

Authors:  Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Biophys J       Date:  2015-08-11       Impact factor: 4.033

Review 4.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

5.  Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells.

Authors:  Talyn Chu; Minjian Ni; Chunmo Chen; Shreeram Akilesh; Jessica A Hamerman
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

Review 6.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 7.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

8.  Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia.

Authors:  I M Ghobrial; R Redd; P Armand; R Banwait; E Boswell; S Chuma; D Huynh; A Sacco; A M Roccaro; A Perilla-Glen; K Noonan; M MacNabb; H Leblebjian; D Warren; P Henrick; J J Castillo; P G Richardson; J Matous; E Weller; S P Treon
Journal:  Leukemia       Date:  2015-07-03       Impact factor: 11.528

9.  Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.

Authors:  Yi Liu; Xiao-Li Jiang; Yu Liu; Ding-Sheng Jiang; Yan Zhang; Rui Zhang; Yingjie Chen; Qinglin Yang; Xiao-Dong Zhang; Guo-Chang Fan; Hongliang Li
Journal:  Cardiovasc Res       Date:  2013-11-26       Impact factor: 10.787

10.  Characterization of Lamprey IL-17 Family Members and Their Receptors.

Authors:  Qifeng Han; Sabyasachi Das; Masayuki Hirano; Stephen J Holland; Nathanael McCurley; Peng Guo; Charles S Rosenberg; Thomas Boehm; Max D Cooper
Journal:  J Immunol       Date:  2015-10-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.